Several previous studies have showed that the protein levels of PRKD3 were higher in breast cancer tissues than in the paracancerous tissues and played an important role in breast cancer promoting processes, suggesting that PRKD3 could be a noval target for developing new therapeutic strategies in breast cancer. This evidence concerns the gene PRKD3 and breast carcinoma.